Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc. AGRX

Alternate Symbol(s):  AGXRW

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.


Recent & Breaking News (NDAQ:AGRX)

Agile Therapeutics Reports Third Quarter 2014 Financial Results

GlobeNewswire November 13, 2014

Agile Therapeutics Appoints James P. Tursi, M.D. to Its Board of Directors

GlobeNewswire October 1, 2014

Agile Announces Dosing of First Patients in Twirla(R) Phase 3 SECURE Study

GlobeNewswire September 29, 2014

Agile to Present at the 21st Annual BioCentury NewsMakers Conference

GlobeNewswire September 22, 2014

Agile Initiates Phase 3 SECURE Study for Twirla(TM)

GlobeNewswire September 16, 2014

Agile Therapeutics to Ring the NASDAQ Stock Market Closing Bell

GlobeNewswire September 2, 2014

Agile Therapeutics, Inc. (NASDAQ: AGRX) to Ring the NASDAQ Stock Market Closing Bell

GlobeNewswire August 29, 2014

Agile Therapeutics Reports Second Quarter 2014 Financial Results

GlobeNewswire August 14, 2014

Agile Therapeutics Announces Allowance of Additional Patent Claims for Skinfusion®

PR Newswire July 17, 2014

Agile Therapeutics Joins Russell Microcap® Index

PR Newswire June 30, 2014

Agile Therapeutics Announces Issuance of New Patent for Its Skinfusion® Transdermal Delivery Device

PR Newswire June 20, 2014

Agile Therapeutics to Participate at the Janney Capital Markets Boston Healthcare 1X1 Corporate Access Day

PR Newswire June 18, 2014

Agile Therapeutics Announces Pricing Of Initial Public Offering

PR Newswire May 22, 2014